Abstract
A total of 88 patients were enrolled in a double-blind comparison of cefaclor and amoxicillin-clavulanic acid for the outpatient treatment of soft tissue infections (abscesses, cellulitis, and impetigo). In 84 clinically evaluable patients, high cure rates were obtained for all treatment groups (64 to 85%). Patients who received amoxicillin-clavulanic acid had a much higher incidence of gastrointestinal side effects than did patients who received cefaclor (34 versus 3%, P less than 0.005). However, only five patients with gastrointestinal reactions to amoxicillin-clavulanic acid had symptoms severe enough to warrant halting the completion of antibiotic therapy.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Ball A. P., Mehtar S., Watson A. Clinical efficacy and tolerance of Augmentin in soft tissue infection. J Antimicrob Chemother. 1982 Jul;10(1):67–74. doi: 10.1093/jac/10.1.67. [DOI] [PubMed] [Google Scholar]
- Barry A. L., Garcia F., Thrupp L. D. An improved single-disk method for testing the antibiotic susceptibility of rapidly-growing pathogens. Am J Clin Pathol. 1970 Feb;53(2):149–158. doi: 10.1093/ajcp/53.2.149. [DOI] [PubMed] [Google Scholar]
- Brodie N. H., McGhie R. L., O'Hara H., O'Hara J., Rahman M. K., Vallé-Jones J. C. A double-blind study comparing cefaclor and amoxycillin in the treatment of respiratory tract infections in general practice. Pharmatherapeutica. 1980;2(7):494–498. [PubMed] [Google Scholar]
- Brogden R. N., Carmine A., Heel R. C., Morley P. A., Speight T. M., Avery G. S. Amoxycillin/clavulanic acid: a review of its antibacterial activity, pharmacokinetics and therapeutic use. Drugs. 1981 Nov;22(5):337–362. doi: 10.2165/00003495-198122050-00001. [DOI] [PubMed] [Google Scholar]
- Derry J. E. Evaluation of cefaclor. Am J Hosp Pharm. 1981 Jan;38(1):54–58. [PubMed] [Google Scholar]
- Fuchs P. C., Barry A. L., Thornsberry C., Gavan T. L., Jones R. N. In vitro evaluation of Augmentin by broth microdilution and disk diffusion susceptibility testing: regression analysis, tentative interpretive criteria, and quality control limits. Antimicrob Agents Chemother. 1983 Jul;24(1):31–38. doi: 10.1128/aac.24.1.31. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kammer R. B. Cefaclor in management of streptococcal pharyngitis, otitis media, and skin infections. Ann Otol Rhinol Laryngol Suppl. 1981 May-Jun;90(3 Pt 3):79–81. doi: 10.1177/00034894810903s219. [DOI] [PubMed] [Google Scholar]
- Law M. R., Holt H. A., Reeves D. S., Hodson M. E. Cefaclor and amoxycillin in the treatment of infective exacerbations of chronic bronchitis. J Antimicrob Chemother. 1983 Jan;11(1):83–88. doi: 10.1093/jac/11.1.83. [DOI] [PubMed] [Google Scholar]
- Neu H. C. Diagnosis and treatment: drugs five years later. Amoxicillin. Ann Intern Med. 1979 Mar;90(3):356–360. doi: 10.7326/0003-4819-90-3-356. [DOI] [PubMed] [Google Scholar]
- Perryman F., Johnson S., Qadri S. M. In vitro activity of augmentin against pathogenic bacteria and its comparison with other antibiotics. Chemotherapy. 1983;29(2):111–115. doi: 10.1159/000238183. [DOI] [PubMed] [Google Scholar]
- Staniforth D. H., Lillystone R. J., Jackson D. Effect of food on the bioavailability and tolerance of clavulanic acid/amoxycillin combination. J Antimicrob Chemother. 1982 Aug;10(2):131–139. doi: 10.1093/jac/10.2.131. [DOI] [PubMed] [Google Scholar]
- Van Landuyt H. W., Pyckavet M., Lambert A. M. Comparative activity of BRL 25.000 with amoxycillin against resistant clinical isolates. J Antimicrob Chemother. 1981 Jan;7(1):65–70. doi: 10.1093/jac/7.1.65. [DOI] [PubMed] [Google Scholar]